Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-25-140870
Filing Date
2025-06-13
Accepted
2025-06-13 17:19:17
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d32947ds3.htm S-3 180304
2 EX-4.5 d32947dex45.htm EX-4.5 67471
3 EX-5.1 d32947dex51.htm EX-5.1 9329
4 EX-23.1 d32947dex231.htm EX-23.1 1966
5 EX-FILING FEES d32947dexfilingfees.htm EX-FILING FEES 21476
6 GRAPHIC g32947dsp42.jpg GRAPHIC 6424
7 GRAPHIC g32947dsp42a.jpg GRAPHIC 4403
8 GRAPHIC g32947dsp43.jpg GRAPHIC 1495
9 GRAPHIC g32947g15b16.jpg GRAPHIC 57195
10 GRAPHIC g32947g88w84.jpg GRAPHIC 40025
  Complete submission text file 0001193125-25-140870.txt   429558
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

EIN.: 471851754 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-288053 | Film No.: 251047726
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)